Everything you need to know about provider referral strategies that work
The playbook for reaching doctor’s offices was pioneered by pharmaceutical companies. Most digital health companies now share that same goal, but lack the expertise to do it. For any business that is providing care delivery, meaning a medical encounter between a provider and a patient, a referral from a primary care physician or another specialist is the ultimate sustainable unlock to growth.
There’s a clear reason for that, which medical device and pharmaceutical companies realized decades ago. Acquiring patients through paid channels, like television advertising, is both expensive and saturated. And even if a patient is intrigued enough by the promotion to talk to their doctor, that might not result in anything. The doctor could push back for a variety of reasons. But if a physician refers that patient to a new therapy or device, and increasingly these days a venture-backed virtual care delivery company, there’s inbuilt trust.
A strong provider referral program also impacts a businesses’ unit economics in a very good way: It’s much better to spend on business development that leads to a steady stream of referrals that continue year-after-year, versus rely on paid channels that will only increase in price over time. Paid marketing is a beast that you have to continue to feed in order to see growth, whereas provider referral programs are all about relationships that compound over time.
Interest in this approach is at an all-time high. According to the results of a recent survey from Bridge, a company that helps care delivery businesses unlock insurance, 47% of patients first use telehealth because their regular doctor offers the option. And 23% get onboarded because their trusted provider — usually a PCP, but sometimes another specialist — refers to them. An example might be a pediatrician recommending Clarity Pediatrics for virtual ADHD treatment, or an endocrinologist suggesting Nourish for telehealth nutrition counseling.
You might be wondering why a provider office would refer to digital health companies at all. Why not just treat them in-house, or send the patient to the local hospital? Well, that’s a fascinating question and a complicated one to unpack. To answer that, and discuss the ins and outs of this strategy, I sat down with Lenny Roth, a former pharmaceutical rep who lived in doctor’s offices for years. Roth’s prior business was entirely focused on helping digital health companies reach provider offices, and he’s advised many of the most successful companies in the space.
Roth, who now leads growth marketing at Candid Health, shared his advice on how to reach provider offices authentically, and without running afoul of the various laws that ensure information sharing is transparent and that doctors are not getting paid to make a referral. We also talked about the specific businesses that have excelled, and those that have struggled. For Second Opinion premium subscribers, let’s dive in.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,
What will AI do for employer healthcare and benefits?
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.
Hospitals as the new go-to-market, lessons from the trenches
Watch the Full Webinar Health systems are entering a new frontier, one where innovation isn’t optional, and meaningful change requires creativity,